Journal of Immunotherapy

The Journal of Immunotherapy, iSBTc's official journal, is a peer reviewed, multidisciplinary journal directed to an audience of immunotherapy and biological therapy physicians and researchers. The Journal publishes original articles in the form of basic studies, clinical studies, and selected abstracts from scientific meetings and conferences.

The Journal of Immunotherapy features rapid publication of articles on immunomodulators, lymphokines, antibodies, cells, and cell products in cancer biology and therapy. Laboratory and preclinical studies, as well as investigative clinical reports, are presented. The Journal emphasizes basic mechanisms and methods for the rapid transfer of technology from the laboratory to the clinic and contains full-length articles, review articles, and short communications.

Journal of Translational Medicine

In 2009, iSBTc partnered with the Journal of Translational Medicine to produce a new open-access journal section titled Tumor Immunology and Biological Cancer Therapy. Edited by long-time iSBTc member Dr. Pedro J. Romero, the subsection complements the society's official journal, the Journal of Immunotherapy, by offering a variety of topics within biological therapy in an open-access online format.

All articles published in iSBTc's online section are available to the public free of charge to allow for maximum reach to investigators in the cancer immunotherapy / biological therapy community. To promote scholarly discussion, a built-in comment feature also allows readers to pose questions and provide comments on articles.

International Society for Biological Therapy of Cancer
555 East Wells Street, Suite 1100
Milwaukee, Wisconsin 53202-3823
Ph: 414-271-2456
E-Mail: info@isbtc.org

©2010 iSBTc
All rights reserved